Discovery of a potent FKBP38 agonist that ameliorates HFD-induced hyperlipidemia via mTOR/P70S6K/SREBPs pathway

The mammalian target of rapamycin (mTOR)-sterol regulatory element-binding proteins (SREBPs) signaling promotes lipogenesis. However, mTOR inhibitors also displayed a significant side effect of hyperlipidemia. Thus, it is essential to develop mTOR-specific inhibitors to inhibit lipogenesis. Here, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Ping-Ting, Xie, Zhi-Shen, Kuang, Yu-Jia, Liu, Shi-Yu, Zeng, Chun, Li, Ping, Liu, E-Hu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642436/
https://www.ncbi.nlm.nih.gov/pubmed/34900535
http://dx.doi.org/10.1016/j.apsb.2021.03.031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642436/
https://www.ncbi.nlm.nih.gov/pubmed/34900535
http://dx.doi.org/10.1016/j.apsb.2021.03.031

Ejemplares similares